Darvocet and Sinusitis - chronic - a phase IV clinical study of FDA data

Summary:

Sinusitis - chronic is reported as a side effect among people who take Darvocet (acetaminophen; propoxyphene hydrochloride), especially for people who are female, 60+ old, also take Zometa, and have Breast cancer metastatic.

The phase IV clinical study analyzes which people have Sinusitis - chronic when taking Darvocet. It is created by eHealthMe based on reports of 11,339 people who have side effects when taking Darvocet from the FDA, and is updated regularly.

What is Darvocet?

Darvocet has active ingredients of acetaminophen; propoxyphene hydrochloride. It is often used in pain. eHealthMe is studying from 12,131 Darvocet users. Check the latest studies of Darvocet.

What is Sinusitis - chronic?

Sinusitis - chronic is found to be associated with 1,017 drugs and 758 conditions by eHealthMe. Check the latest studies of Sinusitis - chronic.

On Jul, 09, 2026

11,339 people reported to have side effects when taking Darvocet.
Among them, 11 people (0.1%) have Sinusitis - chronic.

Could Darvocet cause Sinusitis - chronic?

Among these 11 people:

What is the gender of people who have Sinusitis - chronic when taking Darvocet? *

female: 63.64 %
male: 36.36 %

What is the age of people who have Sinusitis - chronic when taking Darvocet? *

What are other drugs people take besides Darvocet? *

What are other side effects people have besides Sinusitis - chronic? *

Osteonecrosis Of Jaw (death of bone of jaw): 8 people, 72.73%
Osteolysis (dissolution of bone): 7 people, 63.64%
Pain In Extremity: 7 people, 63.64%
Dyspnea (difficult or laboured breathing): 7 people, 63.64%
Abdominal Pain: 6 people, 54.55%
Pain In Jaw: 6 people, 54.55%
Neuropathy Peripheral (surface nerve damage): 6 people, 54.55%
Nausea And Vomiting: 6 people, 54.55%
Nausea (feeling of having an urge to vomit): 6 people, 54.55%
Joint Pain: 6 people, 54.55%

What are the existing conditions these people have? *

Breast Cancer Metastatic: 4 people, 36.36%
Neoplasm Malignant (cancer tumour): 2 people, 18.18%
Multiple Myeloma (cancer of the plasma cells): 2 people, 18.18%
Stress And Anxiety: 2 people, 18.18%
Uterine Leiomyoma (uterine benign tumour derived from smooth muscle): 1 person, 9.09%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 9.09%
Birth Control: 1 person, 9.09%
Breast Cancer: 1 person, 9.09%
Diabetes: 1 person, 9.09%
Diarrhea: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Darvocet and have Sinusitis - chronic?

- Check whether Sinusitis - chronic is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Darvocet:

Darvocet (12,131 reports)

Sinusitis - chronic treatments and more:

Sinusitis - chronic (8,796 reports)

How severe was Sinusitis - chronic and when was it recovered:

Sinusitis - chronic in Darvocet

Expand to all the drugs that have ingredients of acetaminophen; propoxyphene hydrochloride:

Sinusitis - chronic and drugs with ingredients of acetaminophen; propoxyphene hydrochloride

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Darvocet:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Sinusitis - chronic:

Sinusitis - chronic (1,017 drugs)

Browse all the conditions that are associated with Sinusitis - chronic:

Sinusitis - chronic (758 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on acetaminophen; propoxyphene hydrochloride (the active ingredients of Darvocet) and Darvocet (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.